TFRC and systemic lupus erythematosus: Transferrin receptor blockade resulted in lower intracellular iron levels and mTORC1 signalling, which in turn suppressed TH1 and TH17 cells but promoted Treg development and was linked to a less severe course of the disease in lupus‐prone mice [58].